IL129166A0 - Hydroxamic acid derivatives - Google Patents
Hydroxamic acid derivativesInfo
- Publication number
- IL129166A0 IL129166A0 IL12916697A IL12916697A IL129166A0 IL 129166 A0 IL129166 A0 IL 129166A0 IL 12916697 A IL12916697 A IL 12916697A IL 12916697 A IL12916697 A IL 12916697A IL 129166 A0 IL129166 A0 IL 129166A0
- Authority
- IL
- Israel
- Prior art keywords
- acid derivatives
- hydroxamic acid
- hydroxamic
- derivatives
- acid
- Prior art date
Links
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9620572.9A GB9620572D0 (en) | 1996-10-02 | 1996-10-02 | Organic compounds |
| GBGB9706667.4A GB9706667D0 (en) | 1997-04-02 | 1997-04-02 | Organic compounds |
| PCT/EP1997/005376 WO1998014424A1 (en) | 1996-10-02 | 1997-09-30 | Hydroxamic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL129166A0 true IL129166A0 (en) | 2000-02-17 |
Family
ID=26310147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12916697A IL129166A0 (en) | 1996-10-02 | 1997-09-30 | Hydroxamic acid derivatives |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP0929517B1 (de) |
| JP (1) | JP3444898B2 (de) |
| KR (1) | KR20000048811A (de) |
| CN (1) | CN1101807C (de) |
| AR (1) | AR009103A1 (de) |
| AT (1) | ATE219050T1 (de) |
| AU (1) | AU726065B2 (de) |
| BR (1) | BR9712255A (de) |
| CA (1) | CA2267415A1 (de) |
| CO (1) | CO4900034A1 (de) |
| CZ (1) | CZ113999A3 (de) |
| DE (1) | DE69713354T2 (de) |
| DK (1) | DK0929517T3 (de) |
| ES (1) | ES2178759T3 (de) |
| HU (1) | HUP9903892A3 (de) |
| ID (1) | ID22212A (de) |
| IL (1) | IL129166A0 (de) |
| MY (1) | MY127926A (de) |
| NO (1) | NO313457B1 (de) |
| NZ (1) | NZ334908A (de) |
| PE (1) | PE2099A1 (de) |
| PL (1) | PL188518B1 (de) |
| PT (1) | PT929517E (de) |
| RU (1) | RU2196131C2 (de) |
| SI (1) | SI0929517T1 (de) |
| SK (1) | SK43099A3 (de) |
| TR (1) | TR199900725T2 (de) |
| WO (1) | WO1998014424A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003294917A1 (en) * | 2002-12-20 | 2004-07-14 | Novartis Ag | Device and method for delivering mmp inhibitors |
| CA2534352A1 (en) | 2003-08-08 | 2005-02-17 | Arriva Pharmaceuticals, Inc. | Methods of protein production in yeast |
| JP2007528409A (ja) | 2004-03-09 | 2007-10-11 | アリバ ファーマシューティカルズ， インコーポレイテッド | プロテアーゼインヒビターの低用量吸入による慢性閉塞性肺疾患の処置 |
| CN1951912B (zh) * | 2005-10-18 | 2010-05-05 | 上海五洲药业股份有限公司 | 手性脂环烃异羟肟酸衍生物的制备方法 |
| GB0818907D0 (en) * | 2008-10-15 | 2008-11-19 | Isis Innovation | Histone lysine demethylase inhibitors |
| CA3021152A1 (en) * | 2016-04-18 | 2017-10-26 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. | Inhibitors of meprin alpha and beta |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK77487A (da) * | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | Hydroxylaminderivater |
| GB9223904D0 (en) * | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
| DK0822186T3 (da) * | 1994-01-20 | 2000-06-26 | British Biotech Pharm | L-tert-leucin-2-pyridylamid |
| JP3827324B2 (ja) * | 1994-01-22 | 2006-09-27 | ブリテッシュ バイオテック ファーマシューティカルズ リミテッド | 金属タンパク質分解酵素阻害剤 |
| GB9416897D0 (en) * | 1994-08-20 | 1994-10-12 | British Biotech Pharm | Metalloproteinase inhibitors |
| GB9423914D0 (en) * | 1994-11-26 | 1995-01-11 | British Biotech Pharm | Polyether derivatives as metalloproteinase inhibitors |
-
1997
- 1997-09-30 NZ NZ334908A patent/NZ334908A/xx unknown
- 1997-09-30 IL IL12916697A patent/IL129166A0/xx not_active IP Right Cessation
- 1997-09-30 JP JP51623698A patent/JP3444898B2/ja not_active Expired - Fee Related
- 1997-09-30 AR ARP970104491A patent/AR009103A1/es unknown
- 1997-09-30 PE PE1997000874A patent/PE2099A1/es not_active Application Discontinuation
- 1997-09-30 TR TR1999/00725T patent/TR199900725T2/xx unknown
- 1997-09-30 WO PCT/EP1997/005376 patent/WO1998014424A1/en not_active Ceased
- 1997-09-30 DK DK97909339T patent/DK0929517T3/da active
- 1997-09-30 PL PL97332477A patent/PL188518B1/pl not_active IP Right Cessation
- 1997-09-30 SI SI9730357T patent/SI0929517T1/xx unknown
- 1997-09-30 CA CA002267415A patent/CA2267415A1/en not_active Abandoned
- 1997-09-30 ES ES97909339T patent/ES2178759T3/es not_active Expired - Lifetime
- 1997-09-30 DE DE69713354T patent/DE69713354T2/de not_active Expired - Lifetime
- 1997-09-30 HU HU9903892A patent/HUP9903892A3/hu unknown
- 1997-09-30 PT PT97909339T patent/PT929517E/pt unknown
- 1997-09-30 CN CN97198511A patent/CN1101807C/zh not_active Expired - Fee Related
- 1997-09-30 SK SK430-99A patent/SK43099A3/sk unknown
- 1997-09-30 AT AT97909339T patent/ATE219050T1/de not_active IP Right Cessation
- 1997-09-30 BR BR9712255A patent/BR9712255A/pt not_active Application Discontinuation
- 1997-09-30 EP EP97909339A patent/EP0929517B1/de not_active Expired - Lifetime
- 1997-09-30 ID IDW990143D patent/ID22212A/id unknown
- 1997-09-30 RU RU99108792/04A patent/RU2196131C2/ru not_active IP Right Cessation
- 1997-09-30 AU AU47068/97A patent/AU726065B2/en not_active Ceased
- 1997-09-30 KR KR1019990702806A patent/KR20000048811A/ko not_active Ceased
- 1997-09-30 CZ CZ991139A patent/CZ113999A3/cs unknown
- 1997-10-01 CO CO97057298A patent/CO4900034A1/es unknown
- 1997-10-01 MY MYPI97004587A patent/MY127926A/en unknown
-
1999
- 1999-03-30 NO NO19991559A patent/NO313457B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0002960A3 (en) | Aryloxyarylsulfonylamino hydroxamic acid derivatives | |
| AP9701078A0 (en) | Arylsulfonylamino hydroxamic acid derivatives | |
| GB9307956D0 (en) | Hydroxamic acid derivatives | |
| HRP980058B1 (en) | Arylsulfonylamino hydroxamic acid derivatives | |
| GB9626637D0 (en) | Percarboxyilic acid solutions | |
| GB9623908D0 (en) | Amino acid derivatives | |
| HRP980070B1 (en) | Arylsulfonyl hydroxamic acid derivatives | |
| HUP0003881A3 (en) | Amidocarboxylic acid derivatives | |
| HUP0102094A3 (en) | Bicyclic hydroxamic acid derivatives | |
| HU9801044D0 (en) | Sulfonyl-amino-carboxylic acid derivatives | |
| GB9411598D0 (en) | Hydroxamic acid derivatives | |
| EP0774965A4 (de) | Phenoxyphenylessigsäurederivate | |
| HUP9903892A3 (en) | Hydroxamic acid derivatives | |
| ZA9510888B (en) | 3-aryl-tetronic acid derivatives | |
| AU1812197A (en) | Hydroxamic acid derivatives | |
| AU5319898A (en) | Glyoxylic acid amides | |
| SI1003720T1 (en) | Aryloxyarylsulfonylamino hydroxamic acid derivatives | |
| HU9401969D0 (en) | Hydroxamic acid derivatives | |
| GB9408183D0 (en) | Hydroxamic acid derivatives | |
| ZA978800B (en) | Hydroxamic acid derivatives. | |
| ZA95301B (en) | Furazancarboxylic acid derivatives | |
| SI0977733T1 (en) | Arylsulfonylamino hydroxamic acid derivatives | |
| KR0137670B1 (en) | 5-METHYL-5-0-(Ñß-D-GLUCOPYRANOSYL)-D-ERYTHROASCORBIC ACID | |
| GB9402815D0 (en) | Polypyrrolecarboxamidonaphthalenic acid derivatives | |
| HUP9902866A3 (en) | Cytostatic hydroxamic acid derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |